arrow
A

Ayhan Ulusakarya

Paris Saclay University
H指数:17
被引数:1,148

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Is Cytoreductive surgery for unresectable colorectal liver metastases able to improve patient outcome? Results of a pilot prospective study

对于不可切除的结直肠癌肝转移,减瘤手术能否改善患者预后?一项前瞻性初步研究的结果

2026-08-030
PRE
Treatment Intensification with Hepatic Arterial Infusion Chemotherapy in Patients with Liver-Only Colorectal Metastases Still Unresectable After Systemic Induction Chemotherapy: Exploratory Findings From a Prematurely Closed Multicenter Randomized Phase II Study: SULTAN UCGI 30/PRODIGE 53 (NCT03164655)

在经过系统性诱导化疗后肝脏仍存在不可切除的结直肠癌肝转移患者中,采用肝动脉灌注化疗进行强化治疗的探索性发现:一项提前终止的多中心随机II期研究的发现:SULTAN UCGI 30/PRODIGE 53(NCT03164655)

2025-10-210
PRE
Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy - a randomized phase II study - SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol
2020-01-309
OAAI
Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin's lymphoma

地塞米松,大剂量阿糖胞苷和奥沙利铂 (DHAOx) 作为最初难治性或复发性非霍奇金淋巴瘤患者的挽救性治疗

2001-10-0141
PREAI